Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-12-31
pubmed:abstractText
The incidence of acute rejection is considered to be higher after simultaneous pancreas-kidney (SPK) transplantation as compared to renal transplant alone. Therefore, the majority of SPK transplant recipients commonly receive a combination of cyclosporine (CsA) or tracolimus, and azathioprine or mycophenolic mofetyl, corticosteroids and/or antilymphocyte preparations. This study was designed to compare two immunosuppressive protocols for the prevention of acute rejection in patients undergoing SPK transplantation. The primary end-point was the incidence of acute rejection during the first 12 months after transplantation
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0085-2538
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1351-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9767555-Adrenal Cortex Hormones, pubmed-meshheading:9767555-Adult, pubmed-meshheading:9767555-Animals, pubmed-meshheading:9767555-Antilymphocyte Serum, pubmed-meshheading:9767555-Azathioprine, pubmed-meshheading:9767555-Cyclosporine, pubmed-meshheading:9767555-Diabetes Mellitus, Type 1, pubmed-meshheading:9767555-Diabetic Nephropathies, pubmed-meshheading:9767555-Drug Therapy, Combination, pubmed-meshheading:9767555-Female, pubmed-meshheading:9767555-Graft Rejection, pubmed-meshheading:9767555-Humans, pubmed-meshheading:9767555-Immunosuppressive Agents, pubmed-meshheading:9767555-Kidney Transplantation, pubmed-meshheading:9767555-Male, pubmed-meshheading:9767555-Middle Aged, pubmed-meshheading:9767555-Pancreas Transplantation, pubmed-meshheading:9767555-Prospective Studies, pubmed-meshheading:9767555-Rabbits, pubmed-meshheading:9767555-Safety
pubmed:year
1998
pubmed:articleTitle
Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.
pubmed:affiliation
Institut de Transplantation et de Recherche en Transplantation, Nantes University Hospital, France. dcantaro@sante.inserm.fr
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial